1. NHS England. Summary information on the funding and supply of inclisiran (Leqvio). Version 2.0. 3 Apr 2023. https://www.england.nhs.uk/aac/wp-content/uploads/sites/50/2023/04/B1913-summary-information-on-the-funding-and-supply-of-inclisiran-v-april-2023.pdf
2. National Institute for Health and Care Excellence. Inclisiran for treating primary hypercholesterolemia or mixed dyslipidaemia. Final appraisal document. Sep 2021. https://www.nice.org.uk/guidance/indevelopment/gid-ta10703/documents
3. NICE approves new cholesterol lowering drug after NHS strikes deal with manufacturer
4. GP leaders warn over the rollout of cholesterol lowering inclisiran in primary care
5. Royal College of General Practitioners. RCGP and BMA update: Information on the proposals for the prescription of inclisiran in primary care settings. Updated 16 Aug 2022. https://www.rcgp.org.uk/representing-you/policy-areas/inclisiran-position-statement